Search research articles
Contact Us
Filters
Showing results (431-440 of 453) with videos related to
Page
of 46
Sort By:
Hypertension (Dallas, Tex. : 1979)
|
March 14, 2018
Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial)
Karen C Johnson, Paul K Whelton, William C Cushman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 19, 2011
Discovery of new antimalarial chemotypes through chemical methodology and library development
Lauren E Brown, Ken Chih-Chien Cheng, Wan-Guo Wei, et al.
Science (New York, N.Y.)
|
July 26, 2005
Global consequences of land use
Jonathan A Foley, Ruth Defries, Gregory P Asner, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Identifying and treating CLN3 disease outside the central nervous system
Ewa A Ziółkowska, Albina Jablonka-Shariff, Letitia L Williams, et al.
Clinical Pharmacology and Therapeutics
|
November 5, 2010
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1
E M Migoya, R Bergeron, J L Miller, et al.
Biorxiv : the Preprint Server for Biology
|
June 29, 2026
Identification of UCB-9721 as a potent inhibitor of MyoA, the essential class XIV myosin motor of apicomplexan parasites
Anne K Snyder, Filomena Tedesco, Anne Kelsen, et al.
Clinical Trials (London, England)
|
June 7, 2014
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)
Walter T Ambrosius, Kaycee M Sink, Capri G Foy, et al.
The New England Journal of Medicine
|
November 10, 2015
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
, Jackson T Wright, Jeff D Williamson, et al.
The New England Journal of Medicine
|
May 19, 2021
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control
, Cora E Lewis, Lawrence J Fine, et al.
Science Translational Medicine
|
May 12, 2017
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma
Salomon Manier, Daisy Huynh, Yu J Shen, et al.
Page
of 46
Search research articles
Search
Showing results (431-440 of 453) with videos related to
Sort By:
Page
of 46
Hypertension (Dallas, Tex. : 1979)
|
March 14, 2018
Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial)
Karen C Johnson, Paul K Whelton, William C Cushman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 19, 2011
Discovery of new antimalarial chemotypes through chemical methodology and library development
Lauren E Brown, Ken Chih-Chien Cheng, Wan-Guo Wei, et al.
Science (New York, N.Y.)
|
July 26, 2005
Global consequences of land use
Jonathan A Foley, Ruth Defries, Gregory P Asner, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Identifying and treating CLN3 disease outside the central nervous system
Ewa A Ziółkowska, Albina Jablonka-Shariff, Letitia L Williams, et al.
Clinical Pharmacology and Therapeutics
|
November 5, 2010
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1
E M Migoya, R Bergeron, J L Miller, et al.
Biorxiv : the Preprint Server for Biology
|
June 29, 2026
Identification of UCB-9721 as a potent inhibitor of MyoA, the essential class XIV myosin motor of apicomplexan parasites
Anne K Snyder, Filomena Tedesco, Anne Kelsen, et al.
Clinical Trials (London, England)
|
June 7, 2014
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)
Walter T Ambrosius, Kaycee M Sink, Capri G Foy, et al.
The New England Journal of Medicine
|
November 10, 2015
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
, Jackson T Wright, Jeff D Williamson, et al.
The New England Journal of Medicine
|
May 19, 2021
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control
, Cora E Lewis, Lawrence J Fine, et al.
Science Translational Medicine
|
May 12, 2017
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma
Salomon Manier, Daisy Huynh, Yu J Shen, et al.
Page
of 46